1-11 of 11
Hartmut Kirchner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frequency and Clinical Characteristics Associated with Putative CAR Targets ADGRE2, CCR1, CD70, and LILRB2 in Acute Myeloid Leukemia

Rabia Shahswar, Arnold Kloos, Razif Gabdoulline, Sagarajit Mohanty, Christian Koenecke, Martin Wichmann, Blerina Neziri, Piroska Klement, Johannes Schiller, Sabrina Klesse, Alessandro Liebich, Courteney Lai, Jürgen Krauter, MD, Arne Trummer, Walter Fiedler, MD, Hartmut Kirchner, Gerhard Heil, Zhixiong Li, MD, Lothar Hambach, Arnold Ganser, MD, Felicitas Thol, MD, Michael Heuser, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5259.
https://doi.org/10.1182/blood-2018-99-113037
Published: 2018
Journal Articles

Circulating Tumor Cells As a Surrogate Marker for Bone Marrow Minimal Residual Disease and an Adverse Prognostic Factor for Patients with Multiple Myelom

Stefanie Huhn, PhD, Mathias Hänel, MD, Thomas Hielscher, PhD, Uta Bertsch, MD, Hans Jürgen Salwender, Norma Peter, MD, Hartmut Kirchner, Helga Bernhard, MD, Martin Vogel, Ralf Angermund, Martin Goerner, MD, Katja C. Weisel, Jan Duering, Igor W Blau, Niels Weinhold, PhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4359.
https://doi.org/10.1182/blood.V130.Suppl_1.4359.4359
Published: 2017
Journal Articles

Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Richard F. Schlenk, MD, Konstanze Döhner, MD, Michael Heuser, MD, Daniela Späth, MSc, Carina Morlok, Alexander Lamparter, Klaus-Henning Koehne, M.D., Heinz-August Horst, MD, Peter Brossart, MD, Gerhard Held, Andrea Kündgen, M.D., Mark Ringhoffer, MD, Mohammed Wattad, MD, Helmut R. Salih, MD, Katharina S. Goetze, MD, Gerald Wulf, MD, Matthias Theobald, MD, PhD, Mathias J. Rummel, MD, Walter Fiedler, MD, Jörg Westermann, MD, Hans Salwender, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Michael Lübbert, MD, Uwe M. Martens, MD, Richard Greil, MD, Hartmut Kirchner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Sabine Kayser, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Gudrun Göhring, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 3878.
https://doi.org/10.1182/blood.V122.21.3878.3878
Published: 2013
Journal Articles

Pharmacodynamic Analysis Of The Inhibitory Potency Of The Tyrosine Kinase Inhibitor Midostaurin In Combination With Intensive Chemotherapy Including Allogeneic Hematopoietic Stem Cell Transplantation Followed By Maintenance Therapy In FLT3 -ITD Positive Acute Myeloid Leukemia In The Ongoing AMLSG 16-10 Trial

Sabine Kayser, MD, Mark Levis, MD, PhD, Carina Morlok, Andrea Kuendgen, MD, Michael Heuser, MD, Walter Fiedler, MD, Joerg Westermann, MD, Katharina Goetze, MD, Helmut R. Salih, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Heinz A. Horst, MD, Uwe M. Martens, MD, Gerald Wulf, MD, Michael Luebbert, MD, Ph.D., Dominik Wolf, MD, Richard Greil, MD, Claus-Henning Koehne, MD, Mark Ringhoffer, MD, Hartmut Kirchner, MD, Michael Pfreundschuh, MD, Brigitte Schlegelberger, MD, PhD, Patricia Erdmann, Trivikram Rajkhowa, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Arnold Ganser, Hartmut Doehner, MD, Konstanze Doehner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 1283.
https://doi.org/10.1182/blood.V122.21.1283.1283
Published: 2013
Journal Articles

Clinical Impact of TERT A1062T Mutations in Younger Patients with Acute Myeloblastic Leukemia

Katharina Wagner, MD, Anna Both, Frederik Damm, MD, Felicitas Thol, MD, Gudrun Göhring, MD, Michael Heuser, MD, Oliver G. Ottmann, MD, Michael Lübbert, MD, Mohammed Wattad, MD, Lothar Kanz, MD, Günther Schlimok, MD, Aruna Raghavachar, MD, Walter Fiedler, MD, Hartmut Kirchner, MD, Wolfram Brugger, MD, Brigitte Schlegelberger, Gerhard Heil, MD, Arnold Ganser, Jürgen Krauter, Prof. Dr. med.
Journal: Blood
Blood (2012) 120 (21): 1381.
https://doi.org/10.1182/blood.V120.21.1381.1381
Published: 2012
Journal Articles

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

Brief Report
Felicitas Thol, Frederik Damm, Katharina Wagner, Gudrun Göhring, Brigitte Schlegelberger, Dieter Hoelzer, Michael Lübbert, Wolfgang Heit, Lothar Kanz, Günter Schlimok, Aruna Raghavachar, Walter Fiedler, Hartmut Kirchner, Gerhard Heil, Michael Heuser, Jürgen Krauter, Arnold Ganser
Journal: Blood
Blood (2010) 116 (4): 614–616.
https://doi.org/10.1182/blood-2010-03-272146
Published: 2010
Includes: Supplemental data
Journal Articles

Prognostic Factors in Patients Receiving An Allogeneic Stem Cell Transplantation for Relapsed AML. Results of the Prospective AML 295 and 01/99 Studies

Jürgen Krauter, Gerhard Heil, Dieter Hoelzer, MD, PhD, Hans Martin, Oliver G. Ottmann, Jürgen Finke, Michael Lübbert, MD, PhD, Wolfgang Heit, Walter Fiedler, Lothar Kanz, MD, Günter Schlimok, Hartmut Kirchner, Aruna Raghavachar, Wolfram Brugger, Hartmut Döhner, Arnold Ganser, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 344.
https://doi.org/10.1182/blood.V112.11.344.344
Published: 2008
Journal Articles

Prospective Randomized Comparison of High Dose AraC and Autologous Peripheral Blood Stem Cell Transplantation as Late Consolidation for Patients ≤60 Years with Standard Risk AML.

Arnold Ganser, MD, Jürgen Krauter, MD, Dieter Hoelzer, MD, Oliver Ottmann, MD, Hans Martin, MD, Michael Lübbert, MD, Jürgen Finke, MD, Wolf Heit, MD, Walter Fiedler, MD, Lothar Kanz, MD, Günter Schlimok, MD, Hartmut Kirchner, MD, Aruna Raghavachar, MD, Peter Brossart, MD, Wolfram Brugger, MD, Gerhard Heil, MD
Journal: Blood
Blood (2005) 106 (11): 151.
https://doi.org/10.1182/blood.V106.11.151.151
Published: 2005
Journal Articles

Role of Consolidation Therapy in the Treatment of Patients up to 60 Years with High Risk AML.

Jürgen Krauter, MD, Gerhard Heil, MD, Dieter Hoelzer, MD, Oliver Ottmann, MD, Hans Martin, MD, Michael Lübbert, MD, Jürgen Finke, MD, Wolf Heit, MD, Walter Fiedler, MD, Lothar Kanz, MD, Peter Brossart, MD, Günter Schlimok, MD, Hartmut Kirchner, MD, Aruna Raghavachar, MD, Wolfram Brugger, MD, Arnold Ganser, MD
Journal: Blood
Blood (2005) 106 (11): 172.
https://doi.org/10.1182/blood.V106.11.172.172
Published: 2005
Journal Articles

Treatment of Adult Patients with High Risk Acute Myeloblastic Leukemia up to 60 Years: Role of Consolidation Therapy within a Prospective Multicenter Trial.

Jürgen Krauter, M.D., Gerhard Heil, M.D., Dieter Hoelzer, M.D., Oliver Ottmann, M.D., Hans Martin, M.D., Michael Lübbert, M.D., Jürgen Finke, M.D., Wolf Heit, M.D., Walter Fiedler, M.D., Dieter Hossfeld, M.D., Lothar Kanz, M.D., Günter Schlimok, M.D., Hartmut Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Arnold Ganser, M.D.
Journal: Blood
Blood (2004) 104 (11): 618.
https://doi.org/10.1182/blood.V104.11.618.618
Published: 2004
Journal Articles

Late Consolidation for Patients with Standard Risk AML up to 60 Years: Results of a Prospective Randomized Comparison of High Dose AraC and Autologous PBSCT.

Arnold Ganser, M.D., Jürgen Krauter, M.D., Dieter Hoelzer, M.D., Oliver Ottmann, M.D., Hans Martin, M.D., Michael Lübbert, M.D., Jürgen Finke, M.D., Wolf Heit, M.D., Walter Fiedler, M.D., Dieter Hossfeld, M.D., Lothar Kanz, M.D., Günter Schlimok, M.D., Hartmut Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Gerhard Heil, M.D.
Journal: Blood
Blood (2004) 104 (11): 145.
https://doi.org/10.1182/blood.V104.11.145.145
Published: 2004